Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PRFX PainReform Ltd. Ordinary Shares
$0.74 0.07% +0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PRFX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

PainReform Ltd. Ordinary Shares (PRFX)

Loading

Key Stats

Market cap. 2.6M
Enterprise value -8632046
Trailing PE 0.014849499
Forward PE -0.061359867
PEG Ratio -0.061359867
Enterprise to EBITDA 2.037
Enterprise to revenue -278.453
Price to book MRQ 0.1418168
Price to sales TTM 83.52794

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 31000
EBITDA -4237000
Diluted EPS TTM -4.09
Total Cash (MRQ) 11.5M
Current ratio (MRQ) 5.069
Operating Cash Flow (TTM) -4407000

PRFX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PRFX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.